Stereotactic PAncreatic RadioTherapy Adjuvant Therapy

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 6, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Pancreas Cancer
Interventions
RADIATION

Stereotactic Body Radiotherapy (SBRT)

"Postoperative Stereotactic Body Radiation Therapy (SBRT) after tumor resection targeting 2 volumes~* CTV1 (clips+isotropic 5mm expansion, edited on anatomic barriers): receiving 40 Gy in 5 fractions of 8 Gy~* CTV2 (CTV1+ anisotropic 10-15 mm expansion including corresponding vessels, retroperitoneum posterior to the SMV/SMA or celiac axis, edited on anatomic barriers): receiving 30 Gy in 5 fractions of 6 Gy."

Trial Locations (1)

20089

Humanitas Research Hospital, Rozzano

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Varian Medical Systems

INDUSTRY

lead

Istituto Clinico Humanitas

OTHER

NCT05043857 - Stereotactic PAncreatic RadioTherapy Adjuvant Therapy | Biotech Hunter | Biotech Hunter